Integra LifeSciences to Host Second Quarter 2022 Financial Results Conference Call on July 27, 2022

Rhea-AI Summary

Integra LifeSciences (NASDAQ: IART) will release its second quarter 2022 financial results on July 27, 2022, before the market opens. Following the release, management will hold a conference call at 8:30 a.m. ET, accessible by calling 800-289-0720 with the passcode 2688312. A webcast of the call will also be available on their website, with a replay accessible until August 7, 2022. Integra specializes in regenerative tissue technologies and offers a broad portfolio of recognized brands aimed at enhancing patient care.

Positive

• Scheduled earnings release on July 27, 2022, indicating ongoing financial updates.
• Management engagement through a conference call, enhancing transparency for investors.

Negative

• None.

PRINCETON, N.J., July 01, 2022 (GLOBE NEWSWIRE) -- )Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, will release second quarter 2022 financial results on Wednesday, July 27, 2022, prior to the market open. In conjunction with the earnings release, Integra’s management team will host a conference call at 8:30 a.m. ET.

The live call is accessible by dialing 800-289-0720 and using the passcode 2688312. A simultaneous webcast of the call will be available via the Company’s website at www.integralife.com.

A webcast replay of the call can be accessed through the Investor Relations homepage of Integra's website at www.integralife.com. A replay of the call will be available until August 7, 2022, by dialing 888-203-1112 and using the passcode 2688312. 

About Integra LifeSciences
Integra LifeSciences is a global leader in regenerative tissue technologies and neurosurgical solutions dedicated to limiting uncertainty for clinicians so they can focus on providing the best patient care. Integra offers a comprehensive portfolio of high quality, leadership brands that include AmnioExcel®, Aurora®, Bactiseal®, BioD, CerebroFlo®, CereLink® Certas® Plus, Codman®, CUSA®, Cytal®, DuraGen®, DuraSeal®, Gentrix®, ICP Express®, Integra®, Licox® , MAYFIELD®, MediHoney®, MicroFrance®, MicroMatrix®, NeuraGen®, NeuraWrap™, PriMatrix®, SurgiMend®, TCC-EZ® and VersaTru®. For the latest news and information about Integra and its products, please visit www.integralife.com. 

Investor Relations:
Chris Ward
(609) 772-7736
chris.ward@integralife.com    

Media Contact:
Laurene Isip
(609) 208-8121
laurene.isip@integralife.com 

 

FAQ

When will Integra LifeSciences announce its Q2 2022 earnings?

Integra LifeSciences will announce its Q2 2022 earnings on July 27, 2022.

What time is the Integra LifeSciences Q2 earnings call?

The earnings call is scheduled for 8:30 a.m. ET on July 27, 2022.

How can investors access the earnings call for Integra LifeSciences?

Investors can access the earnings call by dialing 800-289-0720 and using passcode 2688312, or via a webcast on the company's website.

How long will the Integra LifeSciences earnings call replay be available?

The earnings call replay will be available until August 7, 2022.

What are the main products offered by Integra LifeSciences?

Integra offers a comprehensive portfolio including AmnioExcel®, Aurora®, DuraGen®, and many other brands in regenerative tissue technologies.